Motivating Smokers in the Hospital Pulmonary Function Laboratory to Quit Smoking by Use of the Lung Age Concept

Kaminsky, David A.; Marcy, Theodore W.; Dorwaldt, Anne L.; Pinckney, Richard G.; DeSarno, Michael; Solomon, Laura J.; Hughes, John R.

doi:10.1093/ntr/ntr096

Cited by 23 publications

(48 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This includes the National Lung Screening Trial (Grannis, 2014), the results of which could be interpreted to indicate that smokers who receive negative (high risk) lung screening results are more likely to quit, or, on the other hand, that smokers receiving neutral or positive (low risk) lung screening results are less likely to quit (Kaminsky et al, 2011). This highlights the need for randomized studies.…”

Section: Introductionmentioning

confidence: 99%

The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study

Foulds

Veldheer

Hrabovsky

et al. 2015

Drug and Alcohol Dependence

View full text Add to dashboard Cite

Background A brief “Lung Age” feedback intervention has shown promise for personalizing the health impact of smoking and promoting cessation in unselected smokers. Now that many healthcare organizations provide face-to-face cessation services, it is reasonable to ask whether such motivational feedback of lung function tests might improve treatment compliance and cessation rates in smokers wanting to quit. This study assessed effects of baseline motivational spirometry-based “Lung Age” feedback on treatment compliance and tobacco abstinence at 28-day follow-up. Methods This randomized controlled pilot study took place in Penn State University-affiliated outpatient medical practices. Participants were 225 adult smokers (≥ 5 cigarettes/day) willing to attend tobacco dependence treatment. At assessment lung function (FEV-1) and exhaled carbon-monoxide (CO) were assessed. The Intervention group (n=120) were randomly allocated to receive motivational “Lung Age” feedback estimated by FEV-1 and on exhaled CO; Control group (n=105) received minimal feedback. Participants were offered 6 weekly group smoking cessation sessions and nicotine patches and followed-up 28 days after target quit date. The primary outcome measure was self-reported 7-day tobacco abstinence, confirmed by CO<10ppm at 28-day follow-up. Results Quit rates were similar at follow-up (Intervention 50.8%; Control 52.4%; p=0.65) after controlling for abstinence predictors. Group attendance and patch use were similar. Among those attending follow-up (n=164, 73%), a greater proportion of the Intervention group had improved lung function (67% v. 46%; p=0.0083). Conclusions Baseline Lung Age feedback did not improve quit rates or compliance at 28-day follow-up in smokers seeking intensive treatment. This study was registered at ClinicalTrials.gov (identifier: NCT01980485).

show abstract

Section: Introductionmentioning

confidence: 99%

The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study

Foulds

Veldheer

Hrabovsky

et al. 2015

Drug and Alcohol Dependence

View full text Add to dashboard Cite

show abstract

“…The lung age concept was initially developed by Morris and Temple [11] to express spirometry results in an easily understandable manner in order to encourage patients to change their smoking behavior. Since the development of the lung age tool, several studies [12, 19] have reported support for the use of lung age to improve smoking quit rates while others have not found an association. [15, 20] Our findings suggest a wide acceptance of the lung age tool among PCPs for use as an aid for smoking cessation among COPD patients who smoke.…”

Section: Discussionmentioning

confidence: 99%

Primary Care Providers’ Views on Using Lung Age as an Aid to Smoking Cessation Counseling for Patients with Chronic Obstructive Pulmonary Disease

Parker

Eltinge

Rafferty

et al. 2015

Lung

View full text Add to dashboard Cite

Purpose Smoking cessation is the primary goal for managing patients with chronic obstructive pulmonary disease (COPD) who smoke. However, previous studies have demonstrated poor cessation rates. The “lung age” concept (an estimate of the age at which the FEV1 would be considered normal) was developed to present spirometry data in an understandable format and to serve as a tool to encourage smokers to quit. Primary care physicians’ (PCPs) views of using lung age to help COPD patients to quit smoking were assessed. Methods Post-intervention interviews were conducted with PCPs in the U.S. who participated in the randomized clinical trial, “Translating the GOLD COPD Guidelines into Primary Care Practice.” Results 29 physicians completed the interview. Themes identified during interviews included: general usefulness of lung age for smoking cessation counseling, ease of understanding the concept, impact on patients’ thoughts of quitting smoking, and comparison to FEV1. Most providers found lung age easy to communicate. Moreover, some found the tool to be less judgmental for smoking cessation and others remarked on the merits of having a simple, tangible number to discuss with their patients. However, some expressed doubt over the long-term benefits of lung age and several others thought that there might be a potential backfire for healthy smokers if their lung age was ≤ to their chronological age. Conclusions This study suggests that lung age was well received by the majority of PCPs and appears feasible to use with COPD patients who smoke. However, further investigation in needed to explore COPD patients’ perspectives of obtaining their lung age to help motivate them to quit in randomized clinical trials.

show abstract

“…Literatürde yer alan birçok çalışma, sigara bırakmanın akciğer yaşına olumlu etkisini ve hastaları motive etmek için spirometri ile hesaplanan akciğer yaşının kullanılabileceğini belirtmektedir. [18,19] Ancak bizim çalışmamızda sigarayı bırakan hastalarda üç ayın sonunda akciğer yaşında anlamlı bir dü-zelme görülmemiştir.…”

Section: Araştırmaunclassified

Effect of smoking cessation on the respiratory functions

Marakoğlu¹,

Kargın²

2015

tahd

View full text Add to dashboard Cite

Motivating Smokers in the Hospital Pulmonary Function Laboratory to Quit Smoking by Use of the Lung Age Concept

Cited by 23 publications

References 38 publications

The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study

The effect of motivational lung age feedback on short-term quit rates in smokers seeking intensive group treatment: A randomized controlled pilot study

Primary Care Providers’ Views on Using Lung Age as an Aid to Smoking Cessation Counseling for Patients with Chronic Obstructive Pulmonary Disease

Effect of smoking cessation on the respiratory functions

Contact Info

Product

Resources

About